Severe Spasticity
Specialist Inpatient Rehabilitation Programme

St Cyril’s rehabilitation unit offers a prompt assessment and admission policy to patients presenting
with severe lower limbs’ spasticity who are not responding to management in the community.
Our team is very experienced in the management of neurological impairments in general and
increased muscle tone management is a specialist interest for both our medical consultant and
therapy staff. Our rehabilitation programme integrates physical and occupational therapy with a
robust medical management which may include invasive interventions such as chemodenervation,
nerve blocks or functional electrical stimulation. Throughout the rehabilitation programme, close
liaison with the patient’s specialists, primary care and community rehabilitation team is secured to
ensure the integration of the programme with the overall management strategy with the patient’s
primary care physicians, specialists, and community teams.


Spasticity means over activity in the muscles which follows damage to the brain or spinal cord.
Spasticity matters because it causes pain and deformity which:
- Increase disability (reduced mobility, self care, ease of hygiene etc)
- Increase complications, e.g. pressure sores
- Feed into a vicious cycle of poor posture which in turn exacerbates the spasticity (1).
Management of spasticity usually takes place in the community with pharmacological management
and physical therapy (2). For some patients, the severity of spasticity is considerable and community
management may fail to provide adequate reduction of the muscles’ tone leading to significant risk of
complications such as permanent joint deformities, refractory chronic pain or pressure sores (3).
Care pathway for spasticity management inpatient service

Self-referrals and referrals by health care professionals are usually considered. However, we
particularly welcome referrals from the patients’ neurologists, rehabilitation specialists or
In most cases a member of St Cyril’s clinical staff will assess the patient prior to admission. However,
under special circumstances patients may be admitted directly based on the information provided by
the referring clinicians.
Initial Assessment
During the initial assessment in the patient’s home, the philosophy of the rehabilitation programme, patient’s expectations and goals will be discussed. For most patients, the admission will be for a period of 8 – 12 weeks. Following this a decision will be made to either continue with the rehabilitation programme or to discharge the patient. The decisions are purely made on clinical grounds and are made in consultation with the patient’s local neurological and rehabilitation team. The rehabilitation programme
Most patients will present with a well recognized set of symptoms and issues including painful spasms, joint deformities, difficulties with posture and positioning. The skin in the pressure areas is often compromised. Medical assessment and management
Medical issues leading to worsening of the spasticity such as urinary tract infections etc will be identified and managed appropriately. The medical management of the high muscle tone may include systemic medications, chemodenervation using agents such as botulium toxin, nerve blocks or functional electrical stimulation (4,5,6). Access to neurosurgical and orthopaedic expertise is ensured with interventions such as intrathecal baclofen, tendon release or rhyzotomies rarely considered in selected patients (7, 8). Management of associated symptoms such as pain can be very challenging and will require close supervision and frequent alterations of medications used. Adequate management of pain is of paramount important as it enables the patient to tolerate the physical therapy which may produce considerable discomfort especially in the early stages. Physical and occupational therapy
For most patients regular and intensive physical therapy is the main stay of management. The physical management will focus on stretching, ensuring appropriate positioning and posture. Several orthotics may be used to maintain the stretches on the injected muscle (9, 10, 11, 12, and 13). Clinical supporting services

All patients will have access to the services of several clinicians and professionals if the need is
identified during assessment or at any point throughout the rehabilitation programme. Patient’s
nutritional needs will be assessed by a nutritionist, swallowing and speech impairments by a speech
and language therapists.

The discharge process will be coordinated with the local services to ensure continuity of the
approach, maintaining and building on the achievements made during the inpatient stay. Long term
support and collaborative work with the local teams are an integral aspect of the philosophy of our
specialist service.
Input of different disciplines during admission

The following is an estimate of the expected input from our clinical team:
Occupational therapy: once / twice a day Indicators of effectiveness and service monitoring

The following outcome measures will be evaluated on admission, 6 weekly and on discharge:
- Functional Independence Measure (FIM) - Barthel Score 2. SF-36 Health Survey Physical Functioning Section 3. Medical review indicating active medical issues addressed 4. Patients questionnaire
The service will be subjected to the same rigorous governance procedures as other clinical services in
the St George’s Health Care Group.
This will include regular clinical audits, comprehensive complaint procedures and risk management
Tariff: Cost on Assessment


1 - Guidelines for the use of Botulinum Toxin (BTX) in the management of spasticity in adults. London: RCP
clinical effectiveness and evaluation unit. July 2002
2- Management of spasrticity and joint deformities In: Multiple Sclerosis: National clinical guidelines for diagnosis
and management in primary and secondary care. . London: RCP clinical effectiveness and evaluation unit. 2004
3- Turton A. Does use of a daily muscle stretch regime prevent development contractures and muscle
stiffness in stroke patients? National Research Register Issue 1, 2001.
4- AY, Kirazli Y, Kismali B, Aksit R. Mechanisms of action of phenol block and botulinus toxin type A in relieving
spasticity. Electrophysiologic investigation and follow-up. Am J Phys Med Rehabil 1999; 78: 344-349.
5- Johnson CA, Wood DE, Swain ID, Tromans AM, Strike P, Burridge JH. A pilot study to investigate the combined
use of botulinum neurotoxin type A and functional electrical stimulation, with physiotherapy, in the treatment of
spastic dropped foot in subacute stroke. Artificial Organs 2002; 26:263-266.
6- Hyman N, Barnes M, Bhakta B et al. Botulinum toxin (Dysport) treatment of hip adductor spasticity
in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.
Journal of Neurology, Neurosurgery & Psychiatry 2000;68:707–12.
7- Beard S, Hunn A, Wight J. Treatments for pain and spasticity in multiple sclerosis: a rapid and
systematic review.
Draft HTA report on pain and spasticity.
8- Sampson FC, Hayward A, Evans G et al. The effectiveness of intrathecal baclofen in the
management of patients with severe spasticity. InterTASC Report, 2000.
9- Turton A. Does use of a daily muscle stretch regime prevent development contractures and muscle
stiffness in stroke patients? National Research Register Issue 1, 2001.
10- Steffen TLM. Low-load, prolonged stretch in the treatment of knee-flexion contractures in nursing
home residents. Physical Therapy 1995;75:886–95.
11- Light K, Nuzik S, Personius W, Barstrom A. Low-load prolonged stretch versus high-load brief
stretch in treating knee flexion contractures. Physical Therapy 1984;64:330–3.
12- Moseley AM. The effect of casting combined with stretching on passive ankle dorsiflexion in
adults with traumatic head injuries. Physical Therapy 1997;77:240–7.
13- Fox P, Richardson J, McInnes B et al. Effectiveness of a bed positioning program for treating older
adults with knee contractures who are institutionalized. Physical Therapy 2000;80:363–72.


Microsoft word - revised miralax 8 12 11.doc

INSTRUCTIONS FOR COLONOSCOPY: MIRALAX/GATORADE DATE: _____________________ TIME: ______________________ PLEASE REPORT TO: _________________________ _________________________ _________________________ *Arrive 45 minutes prior to procedure time to register * PLEASE MAKE ARRANGEMENTS TO HAVE SOMEONE DRIVE YOU HOME BECAUSE YOU WILL BE MEDICATED FOR THIS PROCEDURE. If


Ned Tijdschr Klin Chem Labgeneesk 2004; 29: 295-296 Direct measurement of lithium in whole blood using a capillary electrophoresis microchip E.X. VROUWE1, P. KÖLLING2, R. LUTTGE1 and A. van den BERG1 Introduction Receiving clinically relevant blood parameters evenBlood was obtained performing the finger stickfor off-chip cleaned up sample is a nontrivial analy-method on a volunteer us

© 2010-2017 Pdf Pills Composition